Philogen S.p.A. (BIT:PHIL)
22.60
+0.40 (1.80%)
Sep 25, 2026, 5:35 PM CET
Philogen Revenue
Philogen had revenue of 4.26M EUR in the half year ending June 30, 2026, with 148.95% growth. This brings the company's revenue in the last twelve months to 315.66M, up 272.84% year-over-year. In the year 2025, Philogen had annual revenue of 320.12M with 312.25% growth.
Revenue (ttm)
315.66M
Revenue Growth
+272.84%
P/S Ratio
2.89
Revenue / Employee
1.47M
Employees
214
Market Cap
910.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 320.12M | 242.47M | 312.25% |
| Dec 31, 2024 | 77.65M | 52.53M | 209.12% |
| Dec 31, 2023 | 25.12M | -2.17M | -7.96% |
| Dec 31, 2022 | 27.30M | 22.33M | 449.86% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | 6.35M | -10.17M | -61.58% |
| Dec 31, 2019 | 16.52M | 767.00K | 4.87% |
| Dec 31, 2018 | 15.75M | 1.63M | 11.55% |
| Dec 31, 2017 | 14.12M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| Safilo Group | 957.72M |
| EL.En. | 611.40M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 493.80M |
| Pharmanutra | 143.70M |
Philogen News
- 1 day ago - Philogen Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Philogen Earnings release: Q2 2026 - Filings
- 1 day ago - Philogen Quarterly report: Q2 2026 - Filings
- 4 months ago - Philogen Earnings release: Q1 2026 - Filings
- 6 months ago - Philogen Earnings Call Transcript: H2 2025 - Transcripts
- 6 months ago - Philogen Annual report: H2 2025 - Filings
- 6 months ago - Philogen Earnings release: H2 2025 - Filings
- 10 months ago - Philogen Earnings release: Q3 2025 - Filings